Trump Intervenes to Assist 'Dilbert' Creator Scott Adams' Cancer Treatment Delay

U.S. President Donald Trump has pledged to assist "Dilbert" creator Scott Adams in obtaining timely treatment for his metastatic prostate cancer after Adams publicly appealed for help on social media. Adams, who was approved by his healthcare provider Kaiser Permanente for the targeted radiotherapy drug Pluvicto, reported delays in scheduling the treatment and expressed concern about his rapidly declining health. Trump responded promptly to Adams' plea, with Health and Human Services Secretary Robert F. Kennedy also indicating presidential support. Kaiser Permanente confirmed that Adams' oncology team is working closely with him and highlighted their experience treating over 150 patients with Pluvicto since its approval. The drug, developed by Novartis, combines radioactive particles with tumor-targeting molecules and has been shown to reduce the risk of progression or death in prostate cancer patients by 28%. The situation has sparked commentary on disparities in healthcare access, particularly contrasting the support available to wealthy and high-profile individuals like Adams with the broader public’s challenges in obtaining timely medical care.